Literature DB >> 18604471

No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese population.

Branko Aleksic1,2,3, Masashi Ikeda4,5, Ryoko Ishihara6,5, Shinichi Saito6,5, Toshiya Inada7, Nakao Iwata4,5, Norio Ozaki6,5.   

Abstract

PLP1 is one of the major myelin-related genes. A large body of expression-based studies showed significantly lower levels of the PLP1 messenger ribonucleic acid (mRNA) transcripts in schizophrenia. Moreover, one family-based study identified a weak association signal in a male subset using 487 Chinese family trios. We carried out a population-based association study between PLP1 and schizophrenia in 1,640 subjects. Our data does not support genetic variation in close vicinity or within PLP1 locus as a susceptibility factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604471     DOI: 10.1007/s10038-008-0318-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

Review 1.  Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.

Authors:  Daniel G Stewart; Kenneth L Davis
Journal:  Int Rev Neurobiol       Date:  2004       Impact factor: 3.230

2.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Authors:  Andrew D Skol; Laura J Scott; Gonçalo R Abecasis; Michael Boehnke
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Testing association for markers on the X chromosome.

Authors:  Gang Zheng; Jungnam Joo; Chun Zhang; Nancy L Geller
Journal:  Genet Epidemiol       Date:  2007-12       Impact factor: 2.135

4.  The new genomics: global views of biology.

Authors:  E S Lander
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

5.  Assembly of CNS myelin in the absence of proteolipid protein.

Authors:  M Klugmann; M H Schwab; A Pühlhofer; A Schneider; F Zimmermann; I R Griffiths; K A Nave
Journal:  Neuron       Date:  1997-01       Impact factor: 17.173

6.  Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia.

Authors:  Karolina Aberg; Peter Saetre; Niclas Jareborg; Elena Jazin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

7.  DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia.

Authors:  Kazuya Iwamoto; Miki Bundo; Kazuo Yamada; Hitomi Takao; Yoshimi Iwayama-Shigeno; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

8.  Towards understanding the schizophrenia code: an expanded convergent functional genomics approach.

Authors:  H Le-Niculescu; Y Balaraman; S Patel; J Tan; K Sidhu; R E Jerome; H J Edenberg; R Kuczenski; M A Geyer; J I Nurnberger; S V Faraone; M T Tsuang; A B Niculescu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

9.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia.

Authors:  Christopher Aston; Lixin Jiang; Boris P Sokolov
Journal:  J Neurosci Res       Date:  2004-09-15       Impact factor: 4.164

10.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Authors:  Dmitri Tkachev; Michael L Mimmack; Margaret M Ryan; Matt Wayland; Tom Freeman; Peter B Jones; Michael Starkey; Maree J Webster; Robert H Yolken; Sabine Bahn
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

View more
  3 in total

1.  Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Desiree Abu-Odeh; Susumu Mori; Hao Huang; Kenichi Oishi
Journal:  Schizophr Res       Date:  2009-05-31       Impact factor: 4.939

2.  White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia.

Authors:  Haiyun Xu; Xin-Min Li
Journal:  Schizophr Res Treatment       Date:  2011-08-11

Review 3.  Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia.

Authors:  D A Maas; A Vallès; G J M Martens
Journal:  Transl Psychiatry       Date:  2017-07-18       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.